• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma


41.9100 USD 0.3895 0.94%

As of 14:45:02 ET on 08/29/2014.

Snapshot for Eisai Co Ltd (ESALY)

Open: 41.9100 Day's Range: 41.9100 - 41.9100 Volume: 207
Previous Close: 41.5205 52wk Range: 36.5500 - 43.0300 1-Yr Rtn: +7.21%

Stock Chart for ESALY

No chart data available.
  • ESALY:US 41.9100
  • 1D
  • 1M
  • 1Y
Interactive ESALY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ESALY

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) -
Relative P/E vs. SPX -
Earnings Per Share (JPY) (ttm) -
Est. EPS (JPY) (03/2015) -
Est. PEG Ratio -
Market Cap (M USD) 12,313.61
Shares Outstanding (M) 296.57
30 Day Average Volume 1,015
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.76%
Cash Dividend (USD) 0.7010
Dividend Ex-Date 03/26/2014
5 Year Dividend Growth -0.08%
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ESALY

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for ESALY

Eisai Co., Ltd. produces prescription drugs and medical equipment and sells mainly to sales agents and subsidiaries. Through its subsidiary, Sanko Junyaku, the Company produces and sells diagnostic drugs. Eisai also markets its products through related companies in the US, Europe, and Asia. The Company also manufactures and sells foods, livestock feeds, chemical, and agrochemicals.

Haruo NaitoPresident/CEOHideki HayashiDeputy President
Yutaka TsuchiyaDeputy PresidentHajime ShimizuDeputy President
More Company Profile & Key Executives for ESALY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil